Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Drimenol

Copy Product Info
🥰Excellent

Synonyms:

Catalog No. TN3896 Copy Product Info
Purity: 99.97%
🥰Excellent
Drimenol is a sesquiterpene alcohol derived from edible aromatic plants and possesses broad-spectrum antifungal activity. It exerts its fungicidal effects by disrupting the cell wall/membrane structure of fungi. Drimenol also exhibits cytotoxicity and anticancer potential, and is capable of inducing apoptosis in tumor cells.
Drimenol
Cas No. 468-68-8
TargetMol | Customer service
Customer service consultation
Pack SizePriceUSA StockGlobal StockQuantity
1 mg$497-In Stock
5 mg$1,430-In Stock
10 mg$1,930-In Stock
25 mg$2,870-In Stock
50 mg$3,880-In Stock
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.97%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
Drimenol is a sesquiterpene alcohol derived from edible aromatic plants and possesses broad-spectrum antifungal activity. It exerts its fungicidal effects by disrupting the cell wall/membrane structure of fungi. Drimenol also exhibits cytotoxicity and anticancer potential, and is capable of inducing apoptosis in tumor cells.
In vitro
Method: Human pathogenic fungi (e.g., Candida albicans, Cryptococcus neoformans, Aspergillus fumigatus) were treated with drimenol (4–64 μg/mL), and the minimum inhibitory concentration (MIC) was determined using the broth microdilution method.
Result: Drimenol exhibited broad-spectrum fungicidal activity against various fungi, with MIC values of 8 μg/mL against Cryptococcus neoformans and Aspergillus fumigatus, 30–32 μg/mL against Candida albicans (including fluconazole-resistant strains), and 50 μg/mL against Candida auris [1].
Method: Human melanoma cells A2058 and A375 were treated with drimenol (12–25 μM) for 72 h. Cell viability was assessed by MTT assay, DNA fragmentation was detected by TUNEL assay, and the expression levels of Hsp70, Bcl-2, Bax, and caspase-9 were analyzed by Western blot.
Result: Drimenol dose-dependently inhibited the viability of A2058 and A375 cells, with IC50 values of approximately 33.50 μM and 31.25 μM, respectively. It also induced DNA fragmentation, downregulated Hsp70 and Bcl-2, and upregulated Bax and caspase-9, suggesting that drimenol induces apoptosis through the mitochondrial pathway [1].
In vivo
Method: Ehrlich ascites tumor-bearing mice were treated with Siparuna guianensis essential oil containing drimenol (drimenol content: 13.7 ± 0.2%). Tumor cell count, as well as hepatic malondialdehyde (MDA) and superoxide dismutase (SOD) levels, were measured.
Result: The tumor cell count in the treatment group (59.76 ± 12.33) was significantly reduced compared to the untreated control group (96.88 ± 19.15). Additionally, hepatic MDA levels were decreased, and SOD levels were increased, indicating that the essential oil exerts antitumor and antioxidant effects through drimenol [1].
Chemical Properties
Molecular Weight222.37
FormulaC15H26O
Cas No.468-68-8
Smiles[H][C@@]12CC=C(C)[C@H](CO)[C@@]1(C)CCCC2(C)C
Relative Density.0.921 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 µL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 µL Tween 80 and mix well until fully clarified.

3) Add 450 µL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
µL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: Drimenol chemical structure | Drimenol in vivo | Drimenol in vitro | Drimenol formula | Drimenol molecular weight